Concord Biosciences Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 200

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 2

Concord Biosciences General Information

Description

Provider of contract research and chemical development services. The company's services offers comprehensive capabilities and conducts studies with all species commonly used in nonclinical research providing study information with insightful analysis enabling its clients in the Agricultural Chemicals industry with a comprehensive, integrated suite of services to accelerate drug development through all phases of drug development.

Contact Information

Formerly Known As
Ricerca Biosciences
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Specialty Chemicals
Pharmaceuticals
Corporate Office
  • 10845 Wellness Way
  • Concord, OH 44077
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Concord Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Concord Biosciences‘s full profile, request access.

Request a free trial

Concord Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract research and chemical development services. The company's services offers comprehensive capabilitie
Drug Discovery
Concord, OH
200 As of 2014
00.00
00.000 0000-00-00
000000&0

000000

e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000 000000000
Hamburg, Germany
0000 As of 0000
00000
000000000 00000

000000

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cu
0000 000000000
Bangalore, India
0000 As of 0000
00.000 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Concord Biosciences Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evotec Formerly PE-Backed Hamburg, Germany 0000 00000 000000000 00000
Syngene International Formerly PE-Backed Bangalore, India 0000 00000000000
You’re viewing 2 of 2 competitors. Get the full list »

Concord Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concord Biosciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Concord Biosciences‘s full profile, request access.

Request a free trial

Concord Biosciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Celerion 01-Aug-2010 00000 0000 BPO/Outsource Services
MDS (Discovery & Pre-clinical Operations) 08-Mar-2010 Buyout/LBO 000.00 Drug Delivery 000 00000
To view Concord Biosciences’s complete investments history, request access »

Concord Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Celerion 01-Aug-2010 00000 00000 00 Completed
  • 3 buyers
To view Concord Biosciences’s complete exits history, request access »

Concord Biosciences FAQs

  • When was Concord Biosciences founded?

    Concord Biosciences was founded in 1986.

  • Where is Concord Biosciences headquartered?

    Concord Biosciences is headquartered in Concord, OH.

  • What is the size of Concord Biosciences?

    Concord Biosciences has 200 total employees.

  • What industry is Concord Biosciences in?

    Concord Biosciences’s primary industry is Drug Discovery.

  • Is Concord Biosciences a private or public company?

    Concord Biosciences is a Private company.

  • What is the current valuation of Concord Biosciences?

    The current valuation of Concord Biosciences is 00.000.

  • What is Concord Biosciences’s current revenue?

    The current revenue for Concord Biosciences is 000000.

  • How much funding has Concord Biosciences raised over time?

    Concord Biosciences has raised $5.1M.

  • Who are Concord Biosciences’s investors?

    Bain Capital Ventures, Charter Life Sciences, Early Stage Partners, Everett Partners, and Gladstone Capital Corp BDC are 5 of 10 investors who have invested in Concord Biosciences.

  • Who are Concord Biosciences’s competitors?

    Evotec and Syngene International are competitors of Concord Biosciences.

  • When was Concord Biosciences acquired?

    Concord Biosciences was acquired on 01-Apr-2018.

  • Who acquired Concord Biosciences?

    Concord Biosciences was acquired by Frontage Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »